Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma
Cellular Oncology · 2024
DOI: 10.1007/s13402-024-00948-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Shengqiang Mao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, Center of Precision Medicine, P…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Single-Cell Analysis, Lung Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Clinical Research Incubation Project of West China Hospital of Sichuan University, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, Center of Precision Medicine, Precision Medicine Key Laboratory of Sichuan Province, West China Hospi…
Förderung
- the Clinical Research Incubation Project of West China Hospital of Sichuan University
- the National Natural Science Foundation of China
Zitieren
APA
Mao, S., Wang, Y., Chao, N., Zeng, L., & Zhang, L. (2024). Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma. Cellular Oncology. https://doi.org/10.1007/s13402-024-00948-4
Vancouver
Mao S, Wang Y, Chao N, Zeng L, Zhang L. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma. Cellular Oncology. 2024. doi:10.1007/s13402-024-00948-4
BibTeX
@article{Mao2024,
author = {Mao, Shengqiang and Wang, Yilong and Chao, Ningning and Zeng, Lingyan and Zhang, Li},
title = {Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma},
journal = {Cellular Oncology},
year = {2024},
doi = {10.1007/s13402-024-00948-4}
}
EUVIMED